Skip to content

Datenblatt herunterladen

download
  1. Alles ansehen
  2. Monoclonal

BNUB0510

TGF-beta (Transforming Growth Factor beta)(TGFB/510), 0.2mg/mL

Eine Lieferung in diese Region ist nicht möglich.

SKU:
BNUB0510
Zusätzliche Namen:
ARVD; BSC 1 cell growth inhibitor; CED; Cetermin; Diaphyseal dysplasia 1 (DPD1); Glioblastoma derived T cell suppressor factor (G TSF); Latency-associated peptide (LAP); Polyergin; Transforming growth factor beta 1 (TGF beta1 or TGFB1); TGF beta2 (TGFB2); TGF beta3 (TGFB3); TGFbeta (TGFB)
Konzentration:
0.2 mg/ml
Molekulargewicht:
~13 kDa
Quelle:
Animal
Lagerbedingungen:
2-8[o]C, RT
Hersteller:
Biotium
Host:
Mouse
Reaktivitäten:
Bovine, Canine, Hamster, Human, Mouse, Rat
Buffer:
PBS, 0.05% BSA, 0.05% azide|PBS, 0.05% BSA, 0.05% sodium azide
Immunogen:
Full length recombinant human TGF-beta2 protein
Formulierung:
PBS, 0.05% BSA, 0.05% azide
Klon:
TGFB/510
Uniprot:
P01137, P10600, P61812
Synonyme:
ARVD;ARVD1;BSC-1 cell growth inhibitor;CED;cetermin;DPD1;G-TSF;glioblastoma-derived T-cell suppressor factor;IBDIMDE;LAP;latency-associated peptide;LDS4;LDS5;polyergin;prepro-transforming growth factor beta-1;prepro-transforming growth factor beta-2;prepro-transforming growth factor beta-3;RNHF;TGF-beta-1;TGF-beta1;TGF-beta2;TGF-beta3;TGFB;TGFbeta;transforming growth factor beta-1 proprotein;transforming growth factor beta-2 proprotein;transforming growth factor beta-3 proprotein;transforming growth factor beta1
Weitere Details:
This MAb recognizes TGF beta 1, 2 and 3. TGFs inhibit the growth of epithelial cells and stimulate the growth of mesenchymal cells. Most breast lesions, benign and malignant, involve abnormal proliferation and altered architecture of stromal and/or epithelial elements.
Versandbedingungen:
Ambient